Logo image of FULC

FULCRUM THERAPEUTICS INC (FULC) Stock Analyst Ratings

NASDAQ:FULC - Nasdaq - US3596161097 - Common Stock - Currency: USD

3.85  0 (0%)

After market: 3.85 0 (0%)

Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to FULC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.78. This target is 50.13% above the current price.
FULC was analyzed by 13 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about FULC.
In the previous month the buy percentage consensus was at a similar level.
FULC was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
FULC Historical Analyst RatingsFULC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -65 -59 -53 -47 -41 -35 -29 -23 -17 -11 -5 5 10

Price Target & Forecast

Price Low Median Mean High 3.852.024.085.7814.70 - -47.53% 5.97% 50.13% 281.82%
FULC Current Analyst RatingFULC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2024-11-14 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-11-14 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-09-13 RBC Capital Downgrade Outperform -> Sector Perform
2024-09-13 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-09-12 Leerink Partners Downgrade Outperform -> Market Perform
2024-09-12 Cantor Fitzgerald Downgrade Overweight -> Neutral
2024-09-12 Stifel Downgrade Buy -> Hold
2024-09-12 B of A Securities Downgrade Neutral -> Underperform
2024-09-09 B of A Securities Upgrade Underperform -> Neutral
2024-08-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-05-20 Cantor Fitzgerald Initiate Overweight
2024-05-14 Oppenheimer Maintains Outperform -> Outperform
2024-05-14 Goldman Sachs Upgrade Neutral -> Buy
2024-05-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-13 Goldman Sachs Upgrade Neutral -> Buy
2024-03-13 RBC Capital Initiate Outperform
2024-02-28 Piper Sandler Maintains Overweight -> Overweight
2024-02-28 HC Wainwright & Co. Maintains Buy -> Buy
2024-01-26 Goldman Sachs Maintains Neutral -> Neutral
2024-01-25 Goldman Sachs Maintains Neutral -> Neutral
2023-09-25 Goldman Sachs Initiate Neutral
2023-08-23 HC Wainwright & Co. Upgrade Neutral -> Buy
2023-08-22 Oppenheimer Reiterate Outperform -> Outperform
2023-08-22 Stifel Upgrade Hold -> Buy
2023-08-04 HC Wainwright & Co. Reiterate Neutral -> Neutral
2023-05-16 Oppenheimer Maintains Outperform -> Outperform
2023-05-16 HC Wainwright & Co. Maintains Neutral -> Neutral
2023-05-05 Goldman Sachs Maintains Neutral
2023-05-04 Goldman Sachs Downgrade Buy -> Neutral